SpaceOAR Hydrogel Patient Q&A - Ron

Boca Raton, FL

What do you like to do in your free time?

In my free time, I live an active lifestyle. I enjoy boating, riding my Harley Davidson and playing tennis. I also love to exercise and run.

How did you find out you had prostate cancer?

From the age of 40, I regularly went for an annual physical and prostate health evaluation. When I turned 60, my PSA came back slightly elevated. My Urologist, Dr. Seskin, recommended that I get an MRI. Because the MRI showed lesions, I had to get a biopsy. Unfortunately, the biopsy came back positive.

Describe your treatment journey. Did you consider any other treatment plans and how did you ultimately decide to choose to add SpaceOAR Hydrogel to your plan?

My Gleason Score was 3+4. Dr. Seskin explained that if he were in my position, he would opt for radiation therapy. He highly recommended this treatment approach with SpaceOAR Hydrogel.

After some research and thought, together we decided to move forward with TomoTherapy™ in combination with SpaceOAR Hydrogel.

How did you hear about SpaceOAR Hydrogel?

My Urologist, Dr. Seskin, recommended SpaceOAR Hydrogel.

How did you tolerate the SpaceOAR Hydrogel procedure?

I tolerated the procedure very well. There was slight discomfort in the beginning, but no complications beyond that. The entire procedure took approximately one hour. Two physicians, Dr. Keisch and Dr. Seskin, placed SpaceOAR Hydrogel. I recall Dr. Keisch say, “That’s it. That’s it – exactly where I want it.” From that point on, I felt even more confident that my surrounding organs would be protected during radiation. When the procedure was complete, I was able to go back to work and exercise without any adverse reactions.*

What advice do you have for men recently diagnosed with prostate cancer?

Get SpaceOAR Hydrogel. Also, keep your body strong and be sure to exercise.

Have more questions? We can help.

Sign up to receive more information about SpaceOAR Hydrogel. Our patient education team can provide you with details about how SpaceOAR Hydrogel works, what to ask your doctor and how to find a doctor in your area.

Are you a physician looking for more information? Please click here.

Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

*Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.

Content of this testimonial is for Information Purposes only and does not constitute medical advice. BSC strongly recommends that you consult with your physician on all matters pertaining to your health or to address any questions.

SpaceOAR Hydrogel is intended to temporarily move the rectal wall away from the prostate during the course of radiotherapy treatment for prostate cancer, and in creating this space it is the intent of SpaceOAR Hydrogel to reduce the radiation dose affecting the rectum.

SpaceOAR Hydrogel contains polyethylene glycol (PEG). As with any medical treatment, there are some risks involved with the use of SpaceOAR Hydrogel. Potential complications associated with SpaceOAR Hydrogel include, but are not limited to: pain associated with injection, pain or discomfort from the hydrogel, site inflammation, infection (including abscess), inability to urinate, urgent need to urinate, constipation, rectal muscle spasm, damage to lining of rectum, ulcers, fistula (a hole between rectum and bladder, urethra, or skin below the scrotum), perforation (hole in prostate, bladder, urethra, rectum), necrosis (dead tissue), allergic reaction (local reaction or more severe reaction, such as anaphylaxis), embolism (blood vessel blockage is possible and may happen outside of the pelvis, potentially impacting vital organs or legs), fainting, and bleeding. Please talk to your doctor about the risks and benefits related to using SpaceOAR Hydrogel. If one or more of these complications occur, you may need medical treatment or surgery. URO-1288805-AA

All images are the property of Boston Scientific. All trademarks are the property of their respective owners.

URO-833703-AA JUL 2020